A 48-year-old symptomatic PAD patient after revascularization asks about antithrombotic therapy. Which is guideline-supported to reduce MACE/MALE?...

Question

A 48-year-old symptomatic PAD patient after revascularization asks about antithrombotic therapy. Which is guideline-supported to reduce MACE/MALE?

Accepted Answer

Rivaroxaban 2.5 mg twice daily plus aspirin 81 mg daily

Answer

Aspirin alone only

Answer

Warfarin with INR 2-3

Answer

Dual antiplatelet therapy indefinitely

Answer

Clopidogrel monotherapy only

us-abim MCQ (SBA): Peripheral Artery Disease